Medical/Pharmaceuticals
Picosun Strengthens its Presence in the Healthcare Industries
ESPOO, Finland, May 29, 2019 /PRNewswire/ -- Picosun Group, the global provider of AGILE ALD™ (Atomic Layer Deposition) thin film coating solutions, continues its breakthrough into healthcare industries by supplying ALD technology to produce bioactive coatings on surgical implants at a major, lea...
2019-05-29 17:05
1186
Hill-Rom Unveils New Corporate Logo And Global Brand Identity
CHICAGO, May 28, 2019 /PRNewswire/ -- Global medical technology company Hill-Rom Holdings, Inc. (NYSE: HRC), today announced a global rebrand as Hillrom™ with an updated brand promise of Advancing Connected Care™. "With our rapid advancements in digital health and connected care, we are extendin...
2019-05-28 18:57
6102
IMI launches IMI Corporate Wellness amidst growing concerns for professionals' wellbeing.
HONG KONG, May 28, 2019 /PRNewswire/ -- Integrated Medicine Institute (IMI), Hong Kong's largest natural and integrated medicine clinic, today announced the official launch of its corporate wellness arm. Already at work in global organizations with a presence inHong Kong, IMI Corporate Wellness s...
2019-05-28 09:15
3502
Five Directors of Golden Meditech Voluntarily Resigned Due to Personal Reasons
New Members on Board, the Company's Major Shareholder Maintains Full Confidence in Future Business Development HONG KONG, May 24, 2019 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a l...
2019-05-24 21:50
14069
Menicon Announces Launch of Menicon Bloom Myopia Control Management System
- Launch Features Initial Introduction of Menicon Bloom Night, First and Only CE-approved Orthokeratology Contact Lens inEurope for Myopia Control - NAGOYA, Japan, May 24, 2019 /PRNewswire/ -- Menicon Co., Ltd. announced on May 24 the launch of the Menicon Bloom Myopia Control Management System, ...
2019-05-24 13:00
3823
Elekta Unity MR-linac Receives Regulatory Approval From Japanese Ministry of Health, Labour and Welfare
With the potential to transform how clinicians treat cancer, Japan enters a new era of precision radiation medicine with magnetic resonance radiation therapy TOKYO, May 24, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its Elekta Unity magnetic resonance radiation therapy system ha...
2019-05-24 07:05
7436
/C O R R E C T I O N -- World Federation of Hemophilia/
In the news release, The World Federation of Hemophilia (WFH) welcomes Bayer AG to the WFH Humanitarian Aid Program, issued23-May-2019 by World Federation of Hemophilia over PRNewswire, we are advised by the company that the name 'Bayer AG' should have been 'Bayer'. The complete, corrected rel...
2019-05-24 04:02
2540
Cstone partner Agios Announces the Phase 3 ClarIDHy Trial of TIBSOVO (ivosidenib) Achieved its Primary Endpoint
SUZHOU, China, May 23, 2019 /PRNewswire/ -- The partner of CStone Pharmaceuticals ("Cstone"; HKEX:2616), Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) ("Agios") announced that the global Phase 3 ClarIDHy trial of TIBSOVO (ivosidenib) in previously treated cholangiocarcinoma patients with an isocitr...
2019-05-23 18:36
3672
Bened Biomedical Co., Ltd.: Psychobiotic PS128(TM) found to be a potential solution for Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD)
TAIPEI, , May 23, 2019 /PRNewswire/ -- The possible correlation between autism spectrum disorder (ASD) and gut microbiota has long been explored. A recent study, published in《Nutrients》, shows that a specific probiotic supplementation composed ofLactobacillus plantarum PS128 (Psychobiotic PS128™,...
2019-05-23 11:45
2503
Menarini Ricerche at the ASCO Annual Meeting 2019 With Three Different Projects in Oncology
POMEZIA, Italy, May 23, 2019 /PRNewswire/ -- Menarini Ricerche will present three different projects related to the compounds in clinical development SEL24/MEN1703, MEN1611 and MEN1309/OBT076 at the ASCO Annual Meeting 2019 in Chicago. During the poster session "Breast Cancer – Metastatic" on Jun...
2019-05-23 08:00
2601
Gardner Denver Serving Diverse End Markets by Offering a Broad Range of Mission-Critical Technologies
MELBOURNE, Australia, May 23, 2019 /PRNewswire/ -- In its 160 year history,
spanning from 1859 to 2019, Gardner Denver (www.gardnerdenver.com
2019-05-23 07:00
4042
2019 Competitive Benchmarking of Leading Oncology Organizations: Commercialization Trends That are Shaping the U.S. Solid and Liquid Tumor Marketplaces
PharmaForce International's 2019 Oncology Studies benchmark key expenditures and organizational approaches of leading Oncology sales and marketing organizations around the globe.The United States is just one of five regions that PFI covers in the Oncology market. READING, Pennsylvania, May 23, 2...
2019-05-23 07:00
1558
CEM Corporation Launches New Disruptive Technology for Transforming and Simplifying Microwave Digestion
MATTHEWS, North Carolina, May 22, 2019 /PRNewswire/ -- CEM Corporation, the leading supplier of microwave digestion systems, is pleased to announce the latest breakthrough in vessel technology which dramatically simplifies and improves the overall digestion process. It allows the use of simple di...
2019-05-22 22:17
3452
Experts Discuss Decentralized Manufacturing to Tackle Neglected Tropical Diseases and Promote Universal Health Coverage at World Health Assembly Event
- Global health leaders covered biomanufacturing and neglected tropical diseases (NTDs) during 72nd World Health Assembly - Event focused on innovative science and technology-based solutions to increase access to medicines and biologics DARMSTADT, Germany, May 22, 2019 /PRNewswire/ -- Merck, a ...
2019-05-22 20:00
3097
EpiBone, Inc. Receives FDA Clearance to Commence its First-In-Human, Phase 1/2 Trial of its Bone Product, EB-CMF
Potential breakthrough technology for stem-cell based bone replacement NEW YORK, May 22, 2019 /PRNewswire/ -- EpiBone, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted its Investigational New Drug (IND) clearance to proceed with a Phase 1/2 clinical trial of i...
2019-05-22 20:00
2910
World Brain Day takes on the 'Painful Truth' about Migraine in 2019
On July 22, the World Federation of Neurology is dedicated to sharing powerful information about the most common brain disease in the world-migraine LONDON, May 22, 2019 /PRNewswire/ -- On July 22, the World Federation of Neurology (WFN) is partnering with the International Headache Society (IHS)...
2019-05-22 19:00
1711
New Solution for Scanning Electron Microscopes Includes Immediately Available Color Images for Fast Analyses and Highly Precise Data
New ColorSEM technology from Thermo Fisher Scientific provides scientists more complete sample information and increased productivity HILLSBORO, Oregon, May 22, 2019 /PRNewswire/ -- Scientists, engineers and researchers can now instantly view and analyze meaningful elemental content that is diff...
2019-05-22 04:30
2390
LifeScan Enters into Agreement with Sanvita Medical to Market and Distribute Continuous Glucose Monitoring (CGM) Devices
The two diabetes device companies plan to launch CGM systems beginning in 2020 MALVERN, Pennsylvania, May 22, 2019 /PRNewswire/ -- LifeScan, a world leader in blood glucose monitoring and maker of the iconic OneTouch® brand, today announced it has entered into an exclusive agreement with Sanvit...
2019-05-21 23:05
2052
Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial
Subjects dosed in First-in-Human study of INO-4500 funded by the Coalition for Epidemic Preparedness Innovations Planned for emergency use as a stockpiled vaccine PLYMOUTH MEETING, Pa. and OSLO, Norway, May 21, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO), together with CEPI, ...
2019-05-21 21:00
3927
First Sublingual Ketamine Drug for Treatment of Acute Pain to be Evaluated in End-of-Phase 2 Meeting with FDA
* Racemic sublingual ketamine, Wafermine, is the first sublingual ketamine drug seeking FDA approval for the treatment of moderate to severe acute pain * Wafermine is a Phase 2-ready drug for treatment resistant depression SINGAPORE, May 21, 2019 /PRNewswire/ -- iX Biopharma Ltd (SGX:42C) anno...
2019-05-21 18:11
11154
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 317 media titles]
2024-05-07 08:00
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 312 media titles]
2024-05-08 14:37
OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 306 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 290 media titles]
2024-05-08 16:44
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
14438
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
10191
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
9714
